Rates of overweight and obesity have more than doubled in the United States during the last three decades, according to a new analysis. By 2050, it’s anticipated that 213 million adults (age, > 25 ...

GLP-1 medications like Ozempic and Zepbound are transforming chronic disease and weight management, with perimenopausal women among the most common users. Despite their high use in this group, women ...

We don't typically hear male celebrities talking about using GLP-1 medications for weight loss. But over the years, a handful ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Women who used a GLP-1 before pregnancy were more likely ...

With GLP-1 use rising across the country, major brands are boosting protein, cutting sugar, and reworking formulations and packaging to fit how shoppers are eating today. Stacey Leasca is an ...

Long-term GLP-1 use slows medical cost growth, according to findings published Jan. 13 from professional services firm Aon. The firm analyzed 192,000 GLP-1 users from July 2022 to March 2025, ...

The World Anti-Doping Agency (WADA) said it is now monitoring GLP-1 use among elite athletes, including at the Winter Olympics in Italy. Being ‘monitored’ does not mean a substance is prohibited; ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Diabetes management-dose GLP-1 use reduces recurrent ...

Cost is not the primary barrier keeping Americans from weight loss drugs, despite historically high list prices and inconsistent insurance coverage, according to a March 17 Axios-Ipsos poll. The ...

About one in eight U.S. adults (12%) say they are currently taking a GLP-1 medication such as Ozempic or Wegovy for weight loss, diabetes, heart disease or another chronic condition, a new KFF Health ...